Sister-chromatid exchanges in human lymphocytes exposed during Go to four classes of DNA-damaging chemicals.
Human lymphocytes were treated prior to mitogenic stimulation with varying concentrations of 6 cytostatic drugs representing 4 classes of DNA-damaging chemicals. Afterwards the cells were washed to remove residual chemical and cultured in the presence of bromodeoxyuridine for analysis of sister-chromatid exchanges (SCEs). A dose-related increase in SCEs was observed in cells exposed during Go to the alkylating chemicals mitomycin C, chlorambucil, and thiotepa, while significant increases in SCEs were not noted in cultures exposed to methotrexate, cytarabine, or bleomycin. These findings suggest that not all classes of clatogenic chemicals which induce SCEs in proliferative cells substituted with BUdR are capable of inducing long-lived lesions in the DNA of Go lymphocytes that can lead to SCE formation.
D001761:Bleomycin / Q000494:pharmacology; D002453:Cell Cycle / Q000187:drug effects*; D002699:Chlorambucil / Q000494:pharmacology; D002842:Chromatids / Q000187:drug effects*; D002869:Chromosome Aberrations; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000378:metabolism*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects*; D008727:Methotrexate / Q000494:pharmacology; D008937:Mitomycins / Q000494:pharmacology; D009153:Mutagens / Q000494:pharmacology*; D013852:Thiotepa / Q000494:pharmacology
D008937:Mitomycins; D009153:Mutagens; D003561:Cytarabine; D001761:Bleomycin; D002699:Chlorambucil; D004247:DNA; D013852:Thiotepa; D008727:Methotrexate